STOCK TITAN

Nu Skin (NUS) Chief Product Officer granted 77,941 Class A shares in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nu Skin Enterprises Chief Product Officer Steven Keith Hatchett reported an equity award of 77,941 shares of Class A common stock on March 6, 2026. The shares were acquired as a grant with a reported price of $0.00 per share, indicating a non-cash award. Following this grant, Hatchett's directly held ownership increased to 260,818 shares of Nu Skin Class A common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hatchett Steven Keith

(Last) (First) (Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET

(Street)
PROVO UT 84601

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Product Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 03/06/2026 A 77,941 A $0.00 260,818 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Gregory Belliston as Attorney-in-Fact for Steven Hatchett 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Nu Skin (NUS) report for Steven Keith Hatchett?

Nu Skin reported that Chief Product Officer Steven Keith Hatchett received a grant of 77,941 Class A common shares. The award was recorded at $0.00 per share, indicating a non-cash equity grant that increases his reported ownership stake.

How many Nu Skin (NUS) shares does Steven Keith Hatchett own after this Form 4?

After the reported equity grant, Steven Keith Hatchett directly holds 260,818 shares of Nu Skin Class A common stock. This total reflects the addition of 77,941 shares acquired through a reported grant or award on March 6, 2026.

Was the Nu Skin (NUS) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant or award acquisition, not an open-market stock purchase. Steven Keith Hatchett received 77,941 Class A shares at a reported price of $0.00 per share, consistent with a compensation-related equity award.

What transaction code was used in the Nu Skin (NUS) Form 4 for Hatchett?

The transaction used code "A", defined as a grant, award, or other acquisition. It covers the issuance of 77,941 Class A common shares to Chief Product Officer Steven Keith Hatchett on March 6, 2026, as reported in the filing.

Does the Nu Skin (NUS) Form 4 indicate direct or indirect ownership for these shares?

The Form 4 categorizes the 77,941 granted shares as direct ownership, using ownership code "D". After this grant, Steven Keith Hatchett is reported as directly owning 260,818 Class A common shares of Nu Skin Enterprises.

What type of security did Steven Keith Hatchett receive in the Nu Skin (NUS) Form 4?

The Form 4 shows that Steven Keith Hatchett received Class A Common Stock of Nu Skin Enterprises. The award covered 77,941 shares, recorded at $0.00 per share, increasing his directly held position to 260,818 shares after the transaction.
Nu Skin Enter

NYSE:NUS

View NUS Stock Overview

NUS Rankings

NUS Latest News

NUS Latest SEC Filings

NUS Stock Data

367.21M
45.82M
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO